The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing the effect of immunosuppressive agents for immune-related adverse event management on tumor response.
 
Pankti Reid
No Relationships to Disclose
 
Daniel Olson
No Relationships to Disclose
 
Thomas Gajewski
Stock and Other Ownership Interests - Evelo Therapeutics; Five Prime Therapeutics; Jounce Therapeutics
Consulting or Advisory Role - Abbvie; Adaptimmune; Aduro Biotech; Bayer; FOGPharma; Jounce Therapeutics; Merck; Roche/Genentech
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Licensing to Aduro (Inst); Licensing to BMS (Inst); Licensing to Evelo (Inst)